Table 4.

Occurrence of haematuria at baseline and 2 years after praziquantel treatment

	Before Treatment		2 years Post treatment
	S. haematobium Infected	S. haematobium Uninfected	S. haematobium Infected	S. haematobium Uninfected
Boys	9 (45%)	5 (5.9%)	0	0
Girls	14 (48.3%)	4 (5.1%)	0	0
7–9	8 (42.1%)	3 (3.9%)	0	0
10–13	15 (50%)	6 (6.9%)	0	0